Loading...
|
Please use this identifier to cite or link to this item:
https://ir.cnu.edu.tw/handle/310902800/28679
|
| 標題: | Rimantadine and 2-adamantanamine elicit local anesthesia to cutaneous nociceptive stimuli in a rat model |
| 作者: | Hung, Ching-Hsia
Chu, Chin-Chen
Chen, Yu-Chung
Chen, Yu-Wen
Wang, Jhi-Joung |
| 貢獻者: | 休閒保健管理系 |
| 關鍵字: | infiltrative cutaneous anesthesia
2-adamantanamine
rimantadine
lidocaine |
| 日期: | 2014-04 |
| 上傳時間: | 2015-05-06 21:24:55 (UTC+8) |
| 出版者: | Wiley-Blackwell |
| 摘要: | The aim of this study was to investigate infiltrative cutaneous anesthesia of 2-adamantanamine and rimantadine. After subcutaneous injections of drugs in rats, the blockade of cutaneous trunci muscle reflex by 2-adamantanamine and rimantadine was evaluated. Lidocaine, a common local anesthetic, was used as control. We showed that rimantadine and 2-adamantanamine as well as the local anesthetic lidocaine produced infiltrative anesthesia of skin in a dose-dependent fashion. Saline (vehicle) group displayed no cutaneous anesthesia. The relative potency of these drugs was rimantadine [23.8 (21.1-26.8)]=lidocaine [26.4 (22.7-30.6)]>2-adamantanamine [64.6 (55.0-75.9)] (P<0.01). On an equianesthetic basis [25% effective dose (ED25), ED50, and ED75], rimantadine and 2-adamantanamine had longer duration of action than lidocaine (P<0.05). Neither local injection of saline nor intraperitoneal administration of a large dose of drugs elicited cutaneous anesthesia (data not shown). These data demonstrated for the first time that rimantadine had a similar potent and longer duration of skin infiltrative anesthesia than did lidocaine, whereas 2-adamantanamine had a less potency but longer duration of cutaneous anesthesia than did lidocaine. |
| 關聯: | Fundamental & Clinical Pharmacology, v.28 n.2, pp.199-204 |
| Appears in Collections: | [休閒保健管理系(所)] 期刊論文
|
Files in This Item:
| File |
Description |
Size | Format | |
|---|
| index.html | | 0Kb | HTML | 1616 | View/Open |
|
All items in CNU IR are protected by copyright, with all rights reserved.
|
